Doctor Kei Morikawa

Kumamoto University, Kumamoto (Japan)

Membership: ESC Professional Member

Follow

Contributor content

Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.

Presentation

Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.

ESC 365 is supported by

novartis

Explore sponsored resources